Profiel
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd. and a Director at Tarsis Technology Ltd. He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Actieve functies van Campbell Wilson
| Bedrijven | Functie | Begin |
|---|---|---|
Pharmaceutical Licensing Group Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Campbell Wilson
| Bedrijven | Functie | Einde |
|---|---|---|
| FRONTIER IP GROUP PLC | Directeur/Bestuurslid | 21-04-2023 |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Directeur/Bestuurslid | 13-09-2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Frontier IP Group Plc
Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Technology Services |
















